InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Snisarenko John, Directeur Commercial. Director active across 1 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 9 January 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
012,100 shares0
Common Stock
SEC:0001209191-22-002980:0·
012,100 shares0
Common Stock
SEC:0001209191-22-002980·
2 of 2 declarations
About Snisarenko John
John Snisarenko is the Chief Commercial Officer at Oyster Point Pharma, Inc. He is responsible for the commercial strategy and sales growth of the company. With a strong background in the pharmaceutical sector, Snisarenko plays a key role in business expansion and achieving commercial objectives.
